Sopa Images | Missile | beautiful images
Leading healthcare companies Pfizer And AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year’s annual ‘Choose France’ business summit.
Pfizer said it would invest 500 million euros ($538.5 million) in France to build out research and development in the country, while AstraZeneca announced a $388 million investment for its site in Dunkirk.
Their investment pledge comes as President Emmanuel Macron prepares to open the annual ‘Choose France’ event aimed at attracting major overseas businesses and investors.
France announced earlier on Sunday 100 new jobs in Paris at the Wall Street bank Morgan Stanleyand investments from other companies such as German aviation company Lilium.
Macron wants to enhance Paris’ role as a leading European business capital, even though the city has traditionally lagged behind New York and London on a global scale.
People are closely monitored Z/Yen Survey of Global Financial Centers, published in March, ranked New York as the world’s top financial center, with London in second place. The survey ranked Paris 14th.
